Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SYRS | Syros Pharmaceuticals, Inc. | President & CEO, Director | $312K | +$161K | +106% | Sep 10, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|